Amicus is pioneering next-generation oral therapies for the management of human genetic diseases.

BiPar is developing a potential new class of tumor-selective drugs designed to meet the unmet needs of cancer patients.

Cell Pathways is a development-stage pharmaceutical company focused on novel medications to treat and prevent cancer and certain autoimmune diseases.

Centocor revolutionized the science of immunology and has been a leader in the field of cancer and immune-disorders for over 20 years.

Cerexa is an innovative biopharmaceutical company focused on developing therapies for the treatment of serious and life–threatening infections.

Chimerix develops orally-available, antiviral therapeutics for a broad range of viral diseases. 

CombinatoRx is pioneering the new field of synergistic combination pharmaceuticals to provide a renewable and previously untapped source of novel drug candidates.

Eon Lab is a drug manufacturer that develops, manufactures, and markets a broad range of generic pharmaceutical products.

Esperion is a biopharmaceutical company focused on the discovery and development of therapies for the treatment of cardiovascular disease.

Personalized medicine through population genomics and informatics.

GenVec develops gene therapy products.

Marinus develops novel drugs to treat serious neurological, psychiatric, and pain disorders such as epilepsy and bipolar disorder.

Matrix Pharmaceutical develops novel local and systemic cancer treatments that may improve or extend the lives of people living with cancer.

OraPharma is a specialty pharmaceutical company focused therapeutics for oral health. 

Orthocon is a specialty pharmaceutical and medical device company offering a new approach to the management of postoperative pain. 

Peninsula Pharmaceuticals is developing new antibiotic medications to treat life-threatening infections. 

Phylogix is an early-stage pharmaceutical company developing chemoprotectant compounds.

Pintex is applying a structure-based drug design approach to create novel cancer therapeutics.

Pozen is a pharmaceutical company developing therapeutic advancements for treatment of acute migraine.

Praecis Pharmaceuticals is a biopharmaceutical company focused on Peptide-based therapeutics that have the potential to address unmet medical needs or improve existing therapies. 

Sopherion is a therapeutics platform company initially focused on cancer.

Spaltudaq harnesses the power of the human immune system to treat cancer and infectious diseases. 

Tobira develops novel drugs to help in the treatment of HIV and AIDS.

VaxInnate is developing novel vaccines for pandemic and seasonal influenza.